Biotech - Press Releases

Date	Title	Company
13-Jan-2020	Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related Lymphoma	Actinium Pharmaceuticals, Inc.
13-Jan-2020	Introducing Generate Life Sciences(TM) - A First-Of-Its-Kind Company Focused On Helping Grow And Protect Healthy Families	Generate Life Sciences
13-Jan-2020	Liminal BioSciences Outlines Corporate Priorities for 2020	Liminal BioSciences Inc.
13-Jan-2020	Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting Pelareorep's Unique Ability to Activate the Immune System in Late Stage Multiple Myeloma	Oncolytics Biotech Inc.
13-Jan-2020	Biomica Enters New Agreement with Biose Industrie for Scale-up and GMP Production of Drug Candidates BMC121 & BMC127 for its Immuno-Oncology Program	Biomica
13-Jan-2020	SOM Biotech Achieves Relevant Advances in its Pipeline Leveraging on its Proprietary AI-based Drug Discovery Technology SOM[AI]- PRO	SOM Biotech
13-Jan-2020	Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab	Oncologie Inc.
13-Jan-2020	Nanoform Appoints Head of US Sales	Nanoform
13-Jan-2020	Hansa Biopharma Provides Business Update Ahead of the JP Morgan Global Healthcare Conference	Hansa Biopharma AB
12-Jan-2020	Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference	Luminex Corporation
10-Jan-2020	Paradigm Diagnostics Receives Expanded Medicare Coverage for PCDx for Solid Tumors	Paradigm Diagnostics
10-Jan-2020	Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020	SMi Group
10-Jan-2020	Color & Sanford Health to Scale Leading Genomics Program, Imagenetics	Color
10-Jan-2020	ELASMOGEN SECURES £2 M FUNDING	Elasmogen Ltd
10-Jan-2020	NBE-Therapeutics Closes USD 22M Series C Financing Round	NBE-Therapeutics AG
10-Jan-2020	Glauconix Biosciences Promotes Kimberly Southern to the Position of Chief Executive Officer	Glauconix Biosciences Inc
10-Jan-2020	Galen, an Almac Group Company, Announces Completion of Multi-Million Pound POA Pharma Acquisition	Almac Group
10-Jan-2020	ProBioGen Inks Next Commercial GlymaxX® License with Roche	ProBioGen
10-Jan-2020	BC Platforms Partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers	BC Platforms
10-Jan-2020	HUMMINGBIRD BIOSCIENCE PUBLISHES PRECLINICAL DATA DEMONSTRATING EFFICACY OF HMBD-001 IN HER3 DRIVEN CANCERS	Hummingbird Bioscience